XML 40 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
Subsequent Event
 12 Months Ended
Sep. 30, 2022
Subsequent Events [Abstract]  
Subsequent Event
(18)
Subsequent Event
On October 26, 2022, Meridian acquired select assets from Estel Biosciences, Inc., as part of Meridian’s continued investment in its immunological research and development capabilities. Among other assets, the Company acquired intellectual property that will be incorporated into the Life Science operations in North Brunswick, New Jersey and Memphis, Tennessee for the design and manufacture of recombinant proteins using an insect cell expression system.